Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLE Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04146220
What this trial is testing

Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 32
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Testing effectiveness (Phase 2)UnknownNCT01226147
What this trial is testing

Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Kinki University 20
Early research (Phase 1)Study completedNCT03174587
What this trial is testing

Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07659704
What this trial is testing

CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of Sao Paulo 16
Testing effectiveness (Phase 2)Looking for participantsNCT06155604
What this trial is testing

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

Who this might be right for
Lupus NephritisChronic Kidney Diseases
The University of Hong Kong 150
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Large-scale testing (Phase 3)Study completedNCT04870333
What this trial is testing

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Who this might be right for
Covid19
Cambridge University Hospitals NHS Foundation Trust 2,240
Testing effectiveness (Phase 2)Study completedNCT02550652
What this trial is testing

Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 126
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)UnknownNCT04835883
What this trial is testing

Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Hanyang University Seoul Hospital 10
Not applicableNot Yet RecruitingNCT07706998
What this trial is testing

Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

Who this might be right for
Learning
Nanjing University 50
Large-scale testing (Phase 3)UnknownNCT05631717
What this trial is testing

The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)Study completedNCT05714670
What this trial is testing

The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis

Who this might be right for
Lupus NephritisSLE Nephritis
Ain Shams University 72
Early research (Phase 1)Looking for participantsNCT06676631
What this trial is testing

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

Who this might be right for
Refractory Systemic Lupus ErythematosusRefractory Lupus Nephritis
Guangdong Provincial People's Hospital 18
Early research (Phase 1)Looking for participantsNCT06975787
What this trial is testing

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Regeneron Pharmaceuticals 90
Not applicableNot Yet RecruitingNCT07149402
What this trial is testing

Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus

Who this might be right for
SLE
Assiut University 150
Not applicableUnknownNCT05588830
What this trial is testing

The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study

Who this might be right for
Lupus NephritisBelimumabTelitacicept
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Large-scale testing (Phase 3)Ended earlyNCT05232864
What this trial is testing

Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 31
Next Page